By [ad_1]
Afterward, the kilos virtually invariably creep back, and, virtually as worrying, the burden individuals regain tends to be virtually solely fats, with little muscle. The result’s that they’re typically metabolically much less wholesome than earlier than they’d begun the medication.
However an vital, new, long-term study of people that used after which give up one of many weight-loss medication suggests there could also be a easy, accessible approach to stave off unhealthy weight regain after stopping the medication: train.
Within the examine, individuals who exercised whereas utilizing a weight-loss drug stored off much more of their weight after quitting the medicine than individuals who didn’t work out, they usually maintained extra muscle.
Signe Sørensen Torekov, a professor of biomedical sciences on the College of Copenhagen in Denmark and senior writer of the brand new examine, mentioned the outcomes strongly point out that individuals utilizing the medication might be able to “protect a wholesome weight,” even after they give up the medicine. “However they do have to do train.”
Weight reduction, with a catch
Most weight problems specialists agree that the holy grail of wholesome, long-term weight reduction is upkeep. Shedding kilos is feasible for many individuals, within the brief time period. Protecting it off can appear virtually inconceivable.
The brand new class of GLP-1 diabetes or weight-loss medication, with model names similar to Ozempic, Wegovy, Zepbound and Mounjaro, appear to be intensifying that dynamic. GLP-1 is brief for glucagon-like peptide 1 agonist; these medication mimic the results of the substance GLP-1.
Most individuals lose substantial weight quickly on these medication. But when they cease, the kilos sometimes return virtually as shortly.
However is that this rebound inevitable?
Torekov and her colleagues devised a multiyear, multipronged effort to search out out.
It started with 195 Danish adults with weight problems however no different main sicknesses. They have been placed on a particularly low-calorie weight loss program, beneath the supervision of the scientists, to quickly lose about 30 kilos. Since this was to be a weight-maintenance examine, the scientists needed them to drop kilos quick, after which transfer to the upkeep section.
For that section, the researchers assigned among the volunteers to begin taking Saxenda, recognized generically as liraglutide, an early GLP-1 medicine, to see if the drug would assist them keep and even increase their weight-reduction plan weight reduction. Saxenda is made by Novo Nordisk, the corporate that additionally makes two comparable medication — the diabetes drug Ozempic and the weight-loss drug Wegovy.
(The examine was funded partially by the Novo Nordisk Basis, a charitable group affiliated with Saxenda’s maker. The pharmaceutical firm itself had no oversight of the examine or its outcomes, an organization spokesperson mentioned.)
A separate group of volunteers began the identical drug, but additionally a supervised train program, with twice-weekly, half-hour group spinning courses and quarter-hour of high-intensity, full-body resistance coaching, together with two at-home jogs or comparable exercises. The train was largely vigorous, that means strenuous sufficient that individuals may barely discuss whereas they have been figuring out.
A management group didn’t train and obtained a placebo, as a substitute of liraglutide. (Though the prescribing info for Saxenda says it ought to be used together with a low-calorie weight loss program and elevated bodily exercise, that advice is commonly ignored.)
After a yr, virtually everybody who took the drug had maintained the decrease weight or misplaced extra weight.
These combining the drug and train had misplaced essentially the most, although. They’d dropped about six kilos greater than these on the drug alone, and extra of these kilos consisted of fats, as a substitute of muscle.
What occurred after they stopped the drug
The researchers published those results in 2021 within the New England Journal of Drugs. Then they started essentially the most revelatory facet of their examine. They ended the drugs and train periods for everybody, leaving individuals to keep up — or regain — their weight-loss utterly on their very own.
After a yr handed, the researchers invited all of the volunteers again to the lab. 100 and 9 returned and researchers checked their physique weight, physique composition and present train habits.
For some, the yr had been discouraging. Those that’d earlier taken the weight-loss drug with out train regained about 70 p.c or extra of all the burden they’d misplaced for the reason that begin of the examine. Most of those regained kilos have been within the type of fats, not muscle, so that they wound up with comparatively larger percentages of physique fats than earlier than beginning the drug.
“They’d gained weight in an unhealthy method,” Torekov mentioned.
However those that’d exercised whereas taking the drug had maintained significantly extra of their weight-loss throughout this section. Many remained no less than 10 p.c lighter than on the examine’s begin, and no less than among the weight they’d regained was muscle, leaving them with a more healthy physique composition than the opposite teams.
Exercising simply two hours every week
It’s straightforward to grasp why the exercisers added fewer kilos after stopping the drug, Torekov mentioned. “They have been nonetheless exercising,” even with out supervision or nudging from the scientists. In response to questionnaires and exercise trackers, they often continued to work out for a number of hours every week, voluntarily.
These findings counsel “about two hours every week of vigorous train,” could also be a very good aim for staving off weight regain after ceasing a weight-loss drug, she continued. Mixing cardio and resistance train might be finest.
In the meantime, those that’d taken the drug with out train have been virtually utterly sedentary now, averaging fewer than half-hour of train every week.
“Extra of those who had not exercised whereas medicated had complained of fatigue” throughout remedy and afterward, Torekov mentioned, which can have contributed to their inactivity now.
Total, the outcomes make a powerful case for “the significance of including train to a routine that features a GLP-1 medicine,” mentioned Daniel Drucker, a diabetes skilled and senior investigator on the Lunenfeld-Tanenbaum Analysis Institute in Toronto, whose analysis helped pave the way in which for the GLP-1 medication. He wasn’t concerned with the brand new examine.
“The outcomes are very encouraging,” agreed Robert Kushner, an endocrinologist and professor at Northwestern College Feinberg Faculty of Drugs, who focuses on weight reduction. “However additional research will must be carried out to see if a much less intense train routine” has comparable results on weight upkeep when individuals cease a GLP-1 drug.
The examine has different limitations. It used liraglutide, which isn’t as potent as more-recent weight problems medication. However “I’d anticipate the outcomes to be directionally comparable with the newer GLP-1 medication,” Drucker mentioned.
It additionally concerned comparatively wholesome Danes, who will not be typical of different individuals hoping to drop some pounds. And the examine’s train routine wasn’t merely vigorous, which could be difficult. It was additionally free and intently supervised in the course of the first yr, a luxurious unavailable to many people.
Nonetheless, for now, the examine tells us that to stave off weight regain and maintain onto muscle throughout and after remedy with an weight problems drug, “it’s actually vital you might have an train program,” Torekov mentioned.
Do you might have a health query? E mail YourMove@washpost.com and we might reply your query in a future column.
